Porton Pharma Solutions Ltd. (SHE:300363)
22.68
-0.57 (-2.45%)
Aug 28, 2025, 12:44 PM CST
Porton Pharma Solutions Market Cap
Porton Pharma Solutions has a market cap or net worth of 12.61 billion as of August 27, 2025. Its market cap has increased by 81.68% in one year.
Market Cap
12.61B
Enterprise Value
12.61B
Revenue
3.28B
Ranking
n/a
PE Ratio
n/a
Stock Price
22.68
Market Cap Chart
Since January 29, 2014, Porton Pharma Solutions's market cap has increased from 3.94B to 12.61B, an increase of 219.91%. That is a compound annual growth rate of 10.56%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 27, 2025 | 12.61B | 46.54% |
Dec 31, 2024 | 8.60B | -37.37% |
Dec 29, 2023 | 13.73B | -38.42% |
Dec 30, 2022 | 22.31B | -54.20% |
Dec 31, 2021 | 48.70B | 145.68% |
Dec 31, 2020 | 19.82B | 155.21% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 440.83B |
Shenzhen Mindray Bio-Medical Electronics | 296.91B |
WuXi AppTec | 291.99B |
Sichuan Biokin Pharmaceutical | 136.34B |
Zhangzhou Pientzehuang Pharmaceutical., | 129.10B |
Aier Eye Hospital Group | 127.82B |
Shanghai United Imaging Healthcare | 111.93B |
Yunnan Baiyao Group Co.,Ltd | 103.18B |